1. , , , (2000). Diagnosis of neurological disease. In , , , , eds. Neurology in Clinical Practice, 3rd edn. New York: Marcel Dekker, pp. 3–8.
2. (2000). Diagnosis and the clinical encounter. In , ed. Caplan’s Stroke, 3rd edn. Boston: Butterworth-Heinemann, pp. 51–71.
3. , (2011). The general systemic and neurological examinations. In , ed. The Effective Clinical Neurologist, 3rd edn. Shelton, CT: People’s Medical Publishing House-USA, pp. 63–103.
4. , , , et al., on behalf of the , , , and (2013). Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44: 870–947.
5. , , , et al. (2009). Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke 40: 1522–1525.
6. , (2003). Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 42: 611–618.
7. , , , , et al. (2010). Safety of tPA in stroke mimics and neuroimaging – negative cerebral ischemia. Neurology 74: 1340–1345.
8. (2006). Neuroimaging for headaches. In , ed. Radiology Rounds: A Newsletter for Referring Physicians. Massachusetts, MA: Massachusetts General Hospital, Department of Radiology, vol 4, issue 10.
9. , , , et al. (2013). The Massachusetts General Hospital acute stroke imaging algorithm: an experience and evidence based approachJ NeuroInterventional Surg 5: i7–i12.
10. , , , et al. (1995). Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences. Radiology 196: 773–777.
11. , , , (1996). Sensitivity of new-generation computed tomography in subarachnoid hemorrhage. Acad Emerg Med 3: 16–20.
12. , , , et al. (1988). Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 168: 463–467.
13. , , , , (1990). Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 176: 801–806.
14. , , , et al. (1994). Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR 15: 9–15.
15. , , , et al. (1996). Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 47: 366–375.
16. , , , (2003). Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc 78: 156–160.
17. , , , et al. (2006). Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care 4: 14–17.
18. , , , et al. (1996). Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR 17: 79–85.
19. , , , et al. (2000). Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology 215: 476–482.
20. , , , et al. (2001). Hyperdense sylvian fissure MCA “dot” sign: a CT marker of acute ischemia. Stroke 32: 84–88.
21. , , , et al. (2003). Validation of computed tomographic middle cerebral artery “dot” sign: an angiographic correlation study. Stroke 34: 2636–2640.
22. , , , et al. (2004). Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatr 75: 857–862.
23. , , , et al. (2009). Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke 40: 134–139.
24. , , , et al; National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group, NIH (2005). Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36: 2110–2115.
25. , , , et al. (2006). Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke 37: 973–978.
26. , , , et al; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NIH (2001). Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 286: 2830–2838.
27. , , , et al. (1999). Diffusion MRI in patients with transient ischemic attacks. Stroke 30: 1174–1180.
28. , , , et al. (2001). Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 219: 95–100.
29. (2008). Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25: 457–507.
30. , , , (1997). Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28: 957–960.
31. , , (2005). Neuroimaging of infections. NeuroRx: 2: 324–332.
32. , , , et al. (1995). Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke 26: 807–812.
33. , , , et al. (1999). Identification of major ischemic change: diffusion-weighted imaging versus computed tomography. Stroke 30: 2059–2065.
34. , , , et al. (2002). CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33: 2206–2210.
35. , , , et al. (1999). Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 210: 155–162.
36. , , , et al. (1999). Normal diffusion-weighted MRI during stroke-like deficits. Neurology 52: 1784–1792.
37. , , , et al. (1998). Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 51: 418–426.
38. , , , , (2000). Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31: 1081–1089.
39. , , , et al. (1998). Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR 19: 1061–1066.
40. , , , et al. (1997). Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41: 574–580.
41. , , , , (1998). Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 29: 1783–1790.
42. , , , , (1992). Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 42: 1717–1723.
43. , , , et al. (2000). Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Neurology 54: 1562–1567.
44. , , , et al. (1991). Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNRl 12: 611–620.
45. , , , , (2001). Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms. Stroke 32: 2774–2781.
46. , , , (2001). The value of diffusion-weighted imaging for prediction of lasting deficit in acute stroke: an analysis of 134 patients with acute neurologic deficits. Neuroradiology 43: 435–441.
47. , , , , (2003). Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke 34: 2453–2458.
48. , , , et al. (1999). Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 30: 2644–2650.
49. , , , , (2000). Multiple acute stroke syndrome: marker of embolic disease?Neurology 54: 674–678.
50. , , , , (2005). Clinical significance of detection of multiple acute brain infarcts on diffusion weighted magnetic resonance imaging. J Neurol Neurosurg Psychiatr 76: 514–518.
51. , , , et al. (2004). Detection of acute brainstem infarction by using DWI/MRI. Eur Neurol 52: 145–150.
52. , , , et al. (2002). Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke 33: 2019–2024.
53. , , , (2004). In which patients is diffusion-weighted magnetic resonance imaging most useful in routine stroke care?J Neuroimaging 14: 118–122.
54. , , , et al. (2002). CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 224: 353–360.
55. , , , et al. (2005). Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiology. J Neurol Neurosurg Psychiatr 76: 1520–1524.
56. , , , , (2002). The differences of clinical parameters between small multiple ischemic lesions and single lesion detected by diffusion-weighted MRI. Acta Neurol Scand 106: 24–29.
57. , , , et al. (2005). Identification of embolic stroke patterns by diffusion-weighted MRI in clinically defined lacunar stroke syndromes. Stroke 36: 757–761.
58. , , , et al. (2001). Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol 58: 571–576.
59. , (1985). Effect of methemoglobin formation on the MR appearance of subarachnoid hemorrhage. Radiology 156: 99–103.
60. , , , et al. (1986). MR of hemorrhage: a new approach. AJNR 7: 751–756.
61. , , , , (1985). Intracranial hematomas: imaging by high-field MR. Radiology 157: 87–93.
62. , , , (1991). Mechanisms of MR signal alteration by acute intracerebral blood: old concepts and new theories. AJNR 12: 899–907.
63. , , , et al. (2004). Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292: 1823–1830.
64. , , , (1999). MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 30: 2263–2267.
65. , , (1996). Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 27: 2321–2324.
66. , , , , (1999). A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 30: 765–768.
67. , , , et al (2004). Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35: 502–506.
68. , , (2004). Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging 14: 54–57.
69. , , , et al. (2002). Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33: 95–98.
70. , , , , (2003). Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 60: 511–513.
71. , , , et al; DEFUSE Investigators (2005). Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 65: 1175–1178.
72. , , , et al; SITS investigators (2009). Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatr 80: 273–278.
73. , , , et al. (2002). Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33: 2066–2071.
74. , , , et al. (1999). Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30: 769–772.
75. , , , et al. (2009). CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR 30: 525–531.
76. , , , (2008). Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. J Stroke Cerebrovasc Dis 17: 64–68.
77. , , , et al. (2001). CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 25: 520–528.
78. , , , et al. (2008). Accuracy of the Alberta Stroke Program Early CT Score during the first 3 hours of middle cerebral artery stroke: comparison of noncontrast CT, CT angiography source images, and CT perfusion. AJNR 29: 931–936.
79. , , , et al. (2004). Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr 28: 55–62.
80. , , , et al. (2008). Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39: 379–383.
81. , , , et al. (2002). Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 33: 1821–1826.
82. , , , et al. (2005). Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. AJNR 26: 246–251.
83. , , , et al. (2004). ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke 35: 2472–2476.
84. , , , et al. (2008). An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR 29: 1111–1117.
85. , , , et al. (1999). Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003–2011.
86. , , , et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317–1329.
87. , , , et al. (2009). Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 40: 2276–2293.
88. , , , et al. (2008). Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [published correction appears in Stroke 2010;41:e455]. Stroke 39: 1647–1652.
89. , , , et al. (2004). Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology 233: 101–112.
90. , , , et al. (2003). Very early risk of stroke after a first transient ischemic attack. Stroke 34: e138–e140.
91. , , , et al. (2005). A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 366: 29–36.
92. (1989). Duplex sonography in patients with hemispheric symptoms. J Ultrasound Med 8: 535–540.
93. , , , et al. (1997). Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke 28: 339–342.
94. , (1997). Blood flow velocity measurements for carotid stenosis estimation: interobserver variation and interequipment variability. VASA 26: 210–214.
95. , , , , (1998). Accuracy of carotid duplex is laboratory specific and must be determined by internal audit. Eur J Vasc Endovasc Surg 15: 511–514.
96. , , , , (1997). Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific. Stroke 28: 597–602.
97. , , , , (1995). Noninvasive carotid artery testing: a meta-analytic review. Ann Intern Med 122: 360–367.
98. , , , (2002). Critical review of non- or minimally invasive methods (duplex ultrasonography, MR- and CT-angiography) for evaluating stenosis of the proximal internal carotid artery. Eur J Vasc Endovasc Surg 24: 43–52.
99. , , , et al. (2003). Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology 228: 677–682.
100. , , , (1991). Transcranial Doppler sonographic monitoring in the intensive care unit. J Intensive Care Med 6: 36–44.
101. , (1992). Transcranial Doppler: clinical and experimental uses. Cerebrovasc Brain Metab Rev 4: 122–143.
102. , (2009). Transcranial Doppler evaluation in migraineurs. Neurol Neurochir Pol 43: 162–172.
103. , , (1995). Transcranial color-coded duplex sonography, magnetic resonance angiography, and computed tomography angiography: methods, applications, advantages, and limitations. J Clin Ultrasound 23: 89–111.
104. , , , et al. (1988). Transcranial Doppler evaluation of middle cerebral artery stenosis. J Ultrasound Med 7: 611–616.
105. , , , et al. (2000). Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 10: 1–12.
106. , , (1994). Transcranial Doppler correlation with angiography in detection of intracranial stenosis. Stroke 25: 1931–1934.
107. , , , et al. (2004). Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62: 1468–1481.
108. , , , , (2002). Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 33: 532–536.
109. , , , et al. (1989). Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke 20: 899–903.
110. , , , et al. (2007). The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 68: 2099–2106.
111. , , , et al. (2004). Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351: 2170–2178.
112. , , , et al. (2007). Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 38: 948–954.
113. , , , et al. (2000). Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31: 1812–1816.
114. , , , et al. (2001). Thrombolysis In Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 32: 89–93.
115. , (2005). Are some strokes preventable? The potential role of transcranial Doppler in transient ischaemic attacks of carotid origin. Lancet Neurol 4: 580–586.
116. , , , et al. (2005). Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111: 2233–2240.
117. , , , , (2006). Embolic signals in unselected stroke patients: prevalence and diagnostic benefit. Stroke 37: 2039–2043.
118. , , (2012). Transcranial Doppler with bubble study as a method to detect extracardiac right-to-left shunts in patients with ischemic stroke. J Neuroimaging Aug 28. doi:10.1111/j.1552-6569.2012.00738.x. [Epub ahead of print]
119. , (2004). Perfusion CT and angio CT in the assessment of acute stroke. Neuroradiology 46: 705–715.
120. , , , et al. (2005). Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR 26: 1012–1021.
121. , , , (2000). Computed tomographic angiography findings in 103 patients following vascular events in the posterior circulation: potential and clinical relevance. J Neurol 247: 760–766.
122. , (2001). Value of the CT angiography in the diagnosis of common carotid artery bifurcation disease: CT angiography versus digital subtraction angiography and color flow Doppler. Eur J Radiol 39: 155–162.
123. , , (2002). Transcranial Doppler sonography and CT angiography in patients with atherothrombotic middle cerebral artery stroke. AJNR 23: 1352–1355.
124. , , , et al. (2008). How accurate is CT angiography in evaluating intracranial atherosclerotic disease?Stroke 39: 1184–1188.
125. , , , et al. (2002). Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR 23: 93–101.
126. , , , et al. (2001). Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 32: 2021–2028.
127. , , , , (1999). Intracranial stenoocclusive disease: double-detector helical CT angiography versus digital subtraction angiography. AJNR 20: 791–799.
128. , , , (1998). Duplex scanning and CT angiography in the diagnosis of carotid artery occlusion: a prospective study. Eur J Vasc Endovasc Surg 16: 133–136.
129. , , , , (2004). Management and outcomes of transient ischemic attacks in Ontario. CMAJ 170: 1099–1104.
130. , , , , (2000). CT angiography for the detection and characterization of carotid artery bifurcation disease. Stroke 31: 2168–2174.
131. , , , , (2002). CT angiography in the assessment of carotid artery atherosclerosis. Acta Radiol 43: 116–124.
132. , , , et al. (1999). Internal carotid arterial stenosis: CT angiography with volume rendering. Radiology 210: 673–682.
133. , , , et al. (2001). Carotid artery stenosis: prospective comparison of CT, three-dimensional gadolinium-enhanced MR, and conventional angiography. Radiology 220: 179–185.
134. , , , et al. (2000). Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR 21: 1184–1189.
135. , , , et al. (1999). AHA scientific statement: magnetic resonance angiography: update on applications for extracranial arteries. Circulation 100: 2284–2301.
136. , , , et al. (1998). Magnetic resonance angiography in patients with brain infarction. J Neuroimaging 8: 65–70.
137. , , , et al. (2003) Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke 34: 660–664.
138. , , (2004). Evaluation of carotid artery stenosis: contrast-enhanced magnetic resonance angiography compared with conventional digital subtraction angiography. Can Assoc Radiol J 55: 111–119.
139. 3rd., , , et al. (2001). Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography. Radiology 218: 138–143.
140. , , (1998). Carotid artery stenosis, occlusion, and pseudo-occlusion: first-pass, gadolinium-enhanced, three-dimensional MR angiography: preliminary study. Radiology 209: 95–102.
141. , , , et al. (2000). Accuracy of three-dimensional gadolinium-enhanced MR angiography in the assessment of extracranial carotid artery disease. AJR 175: 455–463.
142. , , , et al. (2002). Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review. BMJ 324: 198.
143. , , , , (2002). Dissection of epiaortic vessels: clinical appearance and potentiality of imaging techniques [in English, Italian]. Radiol Med 107: 35–46.
144. (2000). MR angiography. Br Med Bull 56: 367–377.
145. , (1996). MR angiography of the head and neck. Top Magn Reson Imaging 8: 345–365.
146. , 3rd., , , (2001). Contrast-enhanced magnetic resonance angiography of the cervical vessels: experience with 422 patients. Stroke 32: 2282–2286.
147. , , , et al. (2001). The clinical utility of contrast-enhanced 3D MR angiography for cerebrovascular disease. Neurol Res 23: 767–771.
148. , , , et al. (2004). Craniocervical artery dissection: diagnosis and follow-up with MR imaging and MR angiography. Med Sci Monit 10: MT109–MT116.b
149. , , , et al. (1997). Craniocervical dissections: study strategies in MR imaging and MR angiography [in German]. Rofo 167: 565–571.
150. (2004). Cerebral angiography in the assessment of acute cerebral ischemia: guidelines and recommendations. J Vasc Interv Radiol 15: S57–S66.
151. , , , et al. (2003). Quality improvement guidelines for adult diagnostic neuroangiography: cooperative study between ASITN, ASNR, and SIR [republished from AJNR 2000; 21: 146–150 and J Vasc Interv Radiol 2000 11: 129–134]. J Vasc Interv Radiol 14: S257–S262.
152. , , , et al. (1997). Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council, American Heart Association. Stroke 28: 1480–1497.
153. , , , et al. (1999). Mild carotid artery atherosclerosis: assessment by 3-dimensional time-of-flight magnetic resonance angiography, with reference to intravascular ultrasound imaging and contrast angiography. Stroke 30: 827–833.
154. , , , et al. (1988). Multicenter validation study of real-time ultrasonography, arteriography, and pathology: pathologic evaluation of carotid endarterectomy specimens. Stroke 19: 289–296.
155. , , , , (2002). Imaging of cervical arterial dissections: multi-center study and review of the literature [in French]. J Neuroradiol 29: 257–263.
156. , , , et al. (2001). Cerebral arteriovenous malformations: comparison of novel magnetic resonance angiographic techniques and conventional catheter angiography. Neurosurgery 48: 973–982.
157. , , (1990). Cerebral angiographic risk in mild cerebrovascular disease. Stroke 21: 209–222.
158. , 3rd., , et al. (2007). Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 243: 812–819.
159. , , , et al. (2003). Neurologic complications of cerebral angiography: prospective analysis of 2, 899 procedures and review of the literature. Radiology 227: 522–528.
160. , (2001). Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography. Neurology 56: 1009–1015.
161. , , , et al. (2002). Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke 33: 2003–2008.
162. , , (2007). Carotid and vertebral artery dissections: clinical aspects, imaging features and endovascular treatment. Eur Radiol 17: 820–834.
163. , (2009). The diagnosis and management of supraaortic arterial dissections. Curr Opin Neurol 22: 80–89.
164. , , , et al. (2003). Total occlusion versus hairline residual lumen of the internal carotid arteries: accuracy of single section helical CT angiography. AJNR 24: 1123–1129.
165. , . (1997). Diffusion-weighted MRI: An ECG for “Brain Attack” (editorial, comment). Annals Neurol 41:565–6.
166. , , , et al. (2004). Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke 35: 1652–1658.
167. , , , et al. (2004) Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?Cerebrovasc Dis 17: 182–190.
168. , , , (1998). Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 40: 54–58.
169. , , , et al. (2008). Accuracy of perfusion-CT in predicting malignant middle cerebral artery brain infarction. J Neurol 255: 896–902.
170. , , , et al. (2008). Optimal outcome measures for detecting clinical benefits of early reperfusion: insights from the DEFUSE Study. J Stroke Cerebrovasc Dis 17: 235–240.
171. , , , et al. (2008). Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 39: 2257–2263.
172. , , , et al. (2006). Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 37: 852–858.
173. (2001). New imaging strategies for patient selection for thrombolytic and neuroprotective therapies. Neurology 57: S48–S52.
174. (2003). Measurement of the ischemic penumbra with MRI: it’s about time. Stroke 34: 2533–2534.
175. , , , et al. (2008). Acute stroke imaging research roadmap. Stroke 39: 1621–1628.
176. , , , et al. (2006). Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke evolution (DEFUSE) study. Ann Neurol 60: 508–517.
177. , , , et al. (2008). Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7: 299–309.
178. , , , et al. (2006). Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37: 1227–1231.
179. (2002). Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 33: 306–307.
180. , , , et al. (2005). The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: 66–73.
181. , , , et al. (1997). Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 41: 581–589.
182. , , , et al. (1999). Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 46: 568–578.
183. , , , et al. (1998). Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (< 6.5 hour) ischemic stroke. Neurology 50: 864–870.
184. , , , et al. (2006). Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 37: 1211–1216.
185. , , , et al. (2006). First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy. AJNR 27: 20–25.
186. , , , et al. (2005). Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 36: 980–985.
187. , , , et al. (2006). Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 37: 979–985.
188. , , , et al. (2001). Potential influence of acute CT on inpatient costs in patients with ischemic stroke. Acad Radiol 8: 955–964.
189. , , , et al. (2003). Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR 24: 688–690.
190. , , (2005). Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 64: 1805–1806.
191. , , , et al.; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators (2003). Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491–499.
192. , (2003). Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med 4: S28–S33.
193. , , , et al. (2007). Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography [correction appears in Stroke 2007; 38: e97]. Stroke 38: 2364–2366.
194. , , , et al. (2002). Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 33: 2025–2031.
195. , , , et al. (2002). Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 51: 417–432.
196. , , , et al. (2001). Multisection dynamic CT perfusion for acute cerebral ischemia: the “toggling-table” technique. AJNR 22: 1077–1080.
197. , , , et al. (2009). Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 53: 1621–1628.
198. , , , , (2009). Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment: report of 33 cases. Radiology 250: 371–377.
199. , , (1992). Transcranial Doppler sonography monitoring of local intra-arterial thrombolysis in acute occlusion of the middle cerebral artery. Stroke 23: 284–287.
200. , , , et al. (2008). Rapid assessment of perfusion–diffusion mismatch. Stroke 39: 75–81.
201. , , , et al. (2007). Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. Stroke 38: 941–947.
, , , et al
). Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
. Lancet Neurol 8